Three Years On Clomipramine: Before and After Brain SPECT Study
Tóm tắt
A case is presented of a patient diagnosed with attention deficit disorder, obsessive thinking, anger outbursts, and depression who had a SPECT study prior to treatment and after 3 years of treatment on clomipramine. The follow-up SPECT study showed marked improvement overall in the cerebral perfusion of the brain. At rest marked overactivity was noted in the anterior medial aspects of the frontal lobes, along with “patchy” (increased and decreased) uptake throughout the cortical and subcortical areas of the brain. After treatment for 3 years on clomipramine at 225 mg a day, the follow-up SPECT study revealed a normalization of activity in the anterior medial aspects of the frontal lobes as well as no patchy uptake cortically and subcortically as noted in the study prior to treatment. The clinical usefulness of the SPECT study as it relates to this case is discussed.
Tài liệu tham khảo
Devous MD Sr: SPECT functional brain imaging. In: Kramer EL, Sanger JJ, eds. Clinical SPECT Imaging. New York: Raven Press; 1995:97–128
Lou HC, Henriksen L, Bruhn P: Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch Neurol 1984; 41(8):825–829
Hoehn-Saric R, Pearlson MB, Gordon HJ, et al.: Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Am J Psychiatry 1991; 148:1243–1245
Amen DG, Stubblefield M, Carmichael B, Thisted R: Brain SPECT findings and aggressiveness: Ann Clin Psychiatry 1996; 8(3):129–137
Garfinkel BD, Wender PH, Sloman L, et al.: Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children. J Am Acad Child Psychiatry 1983; 4:343–348
Baxter LR, Schwartz JM, Mazziotta JC, et al.: Cerebral glucose metabolic rates in non-depressed patients with obsessive compulsive disorder. Am J Psychiatry 1988; 145:1560–1563
Baxter LR, Schwartz JM, Guze BH, Bergman K, Szuba MP: PET imaging in obsessive-compulsive disorder with and without depression. J Clin Psychiatry 1990; 51:61–69
Machlin SR, Gordon HJ, Pearlson MB, et al.: Elevated medial-frontal cerebral blood flow in obsessive-compulsive patients: A SPECT study. Am J Psychiatry 1991; 148:1240–1242
Nordahl TE, Benkelfat C, Semple WE, et al.: Cerebral glucose metabolic rates in obsessive-compulsive disorder. Neuropsychopharmacology 1989; 2:23–38 (abstr)
Swedo SE, Schapiro MB, Grady CL: Cerebral glucose metabolism in childhood onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989; 46:518–523
Kinsbourne M: Overfocusing: An apparent subtype of attention deficit-hyperactivity disorder. In: Amir N, Rapin I, Branski D, eds. Pediatric Neurology: Behavior and Cognition of the Child with Brain Dysfunction, Vol 1. Basel: Karger; 1991:18–35
Barrickman L, Noyes R, Kuperman S, et al.: Treatment of ADHD with fluoxetine: A preliminary trial. J Am Acad Child Adolesc Psychiatry 1991; 30(5):762–767
Mirsky AF, Duncan CC: Behavioral and electrophysiological studies of absence epilepsy. In: Avoli, ed. Generalized Epilepsy. Boston: Birkhauser; 1990:254–272
Brown GL, Goodwin FK, Ballenger JC, et al.: Aggression in human correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1979; 1:131–139